We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Meiragtx Holdings Plc
1 own
2 watching
Current Price
$7.95
$0.58
(7.87%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
355.57M
52-Week High
15.87
52-Week Low
5.695
Average Volume
0.23M
Dividend Yield
--
P/E Ratio
--
Market Capitalization355.57M52-Week High15.8752-Week Low5.695Average Volume0.23MDividend Yield--P/E Ratio--What does the Meiragtx Holdings Plc do?
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson s diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.
Read More
How much money does Meiragtx Holdings Plc make?
News & Events about Meiragtx Holdings Plc.
Globe Newswire
3 months ago
Results from the Phase 1/2 MGT009 study presented at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting set the stage for Phase 3 LUMEOS trial of botaretigene sparoparvovec in XLRP, which is actively dosing patientsLONDONandNEW YORK, Oct. 01, 2022 (GLOBE NEWSWIRE) -- MeiraGTx ...
Globe Newswire
4 months ago
--Manufacturing facilities built to accelerate development and delivery of advanced medicines to patients using state-of-the-art technology at scale, with quality appropriate for commercialization --Site reflects MeiraGTxs unique, end-to-end approach to gene therapy manufacturing to expedite ...
Globe Newswire
5 months ago
-- Recent Positive Topline Data from the Phase 1/2 Trial of Botaretigene Sparoparvovec (AAV-RPGR) for the Treatment of X-linked Retinitis Pigmentosa (XLRP) -- Financing Secured by Manufacturing Facilities Extends Cash Runway to Fourth Quarter 2024 LONDONandNEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE...
Ticker Report
9 months ago
Nisa Investment Advisors LLC acquired a new stake in MeiraGTx Holdings plc (NASDAQ:MGTX Get Rating) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,760 shares of the company’...
Zolmax
10 months ago
Dimensional Fund Advisors LP grew its position in shares of MeiraGTx Holdings plc (NASDAQ:MGTX Get Rating) by 27.6% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 238,590 shares of the companys stock after purchasing an ...
Frequently Asked Questions
Frequently Asked Questions
What is Meiragtx Holdings Plc share price today?
Can Indians buy Meiragtx Holdings Plc shares?
How can I buy Meiragtx Holdings Plc shares from India?
Can Fractional shares of Meiragtx Holdings Plc be purchased?
What are the documents required to start investing in Meiragtx Holdings Plc stocks?
What is today’s traded volume of Meiragtx Holdings Plc?
What is today’s market capitalisation of Meiragtx Holdings Plc?
What is the 52-Week High and Low Range of Meiragtx Holdings Plc?
What percentage is Meiragtx Holdings Plc down from its 52-Week High?
What percentage is Meiragtx Holdings Plc up from its 52-Week Low?
Current Price
$7.95
$0.58
(7.87%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.